Article Type » Research News

Research News

January 28, 2019 - 10:09am

Rohan Fernandes, PhD, received more than $1.6 million from the National Institutes of Health to investigate nanoimmunotherapies for cancer

Read More
Members of the GW Cancer Center recently published several journal articles and patient-focused pieces highlighting the Center’s work in patient navigation and survivorship.
January 22, 2019 - 3:56pm

Members of the GW Cancer Center recently published several journal articles and patient-focused pieces highlighting the Center’s work in patient navigation and survivorship.

Read More
January 15, 2019 - 10:00am

For the first time, researchers at the GW School of Medicine and Health Sciences have successfully used the gene-editing tool CRISPR/Cas9 to limit the impact of parasitic worms responsible for schistosomiasis and for liver fluke infection, which...

Read More
Pedro A. Jose, MD, PhD, professor of medicine at the GW School of Medicine and Health Sciences, and Filipino President Rodrigo Duterte
December 21, 2018 - 6:34pm

Pedro A. Jose, MD, PhD, professor of medicine, received special recognition for his research contributions from Filipino President Rodrigo Duterte.

Read More
December 21, 2018 - 1:27pm

Researchers at the GW School of Medicine and Health Sciences will look for unknown genes associated with branchiootorenal spectrum disorders.

Read More
December 13, 2018 - 9:04am

A team from GW led by Adam Friedman, MD, reviewed 35 studies on treatments for prurigo nodularis.

Read More
December 10, 2018 - 8:59am

Researchers at SMHS found dermatologists are interested in learning more about and recommending therapeutic cannabinoids to patients.

Read More
November 8, 2018 - 8:40am

Colin Young, PhD, received $2.4 million for his research on non-alcoholic fatty liver disease

Read More
October 31, 2018 - 11:13am

Researchers from the GW Cancer Center published in JAMA Dermatology on the efficacy of preventative strategies for adverse effects of taxane-based chemotherapy.

Read More
October 11, 2018 - 1:55pm

The GW School of Medicine and Health Sciences is one of only two sites chosen for the first clinical trial of a HIV vaccine candidate.

Read More